Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trialObbina Abani, Carol Adams, Sadia Abbasi et al.|The Lancet|2021Cited by 521
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cellsXiaolong Wei, Mazhar Adli, Jiekun Yang et al.|Proceedings of the National Academy of Sciences|2020Cited by 113